Decompressive hemicraniectomy in cerebral sinus thrombosis: consecutive case series and review of the literature Coutinho, J.M.; Majoie, C.B.L.M.; Coert, B.A.; Stam, J.
Background and Purpose-Thirteen percent of patients with cerebral venous and sinus thrombosis (CVST) has a poor clinical outcome. In patients with a poor prognosis, endovascular thrombolysis can be considered, but this procedure does not appear to be beneficial in patients with impending transtentorial herniation because of large hemorrhagic venous infarcts. Therefore, halfway through 2006, we changed our policy to decompressive hemicraniectomy in these patients. 1 Endovascular thrombolysis may be considered in patients with these risk factors, but its efficacy has not been proven in a randomized trial. Furthermore, in our experience endovascular thrombolysis is not beneficial to patients with impending transtentorial herniation attributable to large infarcts or hemorrhages 2 : It comes too late and cannot prevent further brain stem compression. Therefore, halfway through 2006, we decided to change our policy and treat these patients with decompressive hemicraniectomy. 2 In this case series we describe the first 3 consecutive patients, discuss previous case reports, and suggest a course of action for future research.
Methods and Results-Patients

Methods
Since July 2006, we treated patients with severe CVST and signs of transtentorial herniation with decompressive hemicraniectomy. Indications for surgery are unilateral third nerve dysfunction or deterio-ration on the Glasgow coma score caused by local brain edema or venous infarction with midline shift or obliteration of basal cisterns, and not attributable to seizures.
A large hemicraniectomy was performed, with special effort to extend the decompression toward the temporal skull base. The dura was opened widely to ensure maximal decompression. The cortical surface was covered with hemostatic material (Surgicell), after which the skin, temporal muscle, and fascia flap were closed in 3 layers. Patients received high-dose subcutaneous nadroparin immediately after the diagnosis CVST was made. Postoperatively, nadroparin was continued in prophylactic dosage for 24 hours. Thereafter, dosage was increased to therapeutic range. Patient C only received nadroparin after surgery, because she was operated on immediately after admission.
Follow-up visits were performed at 6 and 12 months after discharge, and outcome was expressed on the modified Rankin Scale (mRS; 0ϭcomplete recovery, 6ϭdeath).
Results
Patient A, a 39-year-old man, was admitted with severe headache, nausea, and disorientation (E 4 M 6 V 5 ). His history included a deep-vein thrombosis of the left leg and a protein C deficiency. The CT-scan showed a left temporal hemorrhagic infarct (Figure, A) and MR-V showed thrombosis of the left transverse and sigmoid sinuses. Despite nadroparin treatment, he deteriorated and became comatose (E 1 M 3 V 1 ) because of enlargement of the hemorrhagic infarct with a 12-mm midline shift (Figure, B ). Hemicraniectomy was subsequently performed. Immediately postoperative the patient showed marked improvement (E 3 M 5 V aphasia ), and the CT-scan showed reduction of midline shift (Figure, C) . At 6 months a right upper quadrant-anopia and a mild expressive aphasia were his only residual symptoms (mRS 2). At 12 months he had resumed all daily activities (mRS 1).
Patient B, a 36-year-old woman, was admitted because of a generalized epileptic seizure (E 4 M 6 V 5 ), after a week of headache and nausea. MR-V showed thrombosis of the superior sagittal sinus and a right-sided parieto-occipital hemorrhagic infarct (volume 96 cm 3 ). Despite nadroparin treatment, she deteriorated and on day 3 developed a depressed consciousness (E 3 M 6 V 4 ) and an enlarging right pupil. CT-scan showed enlargement of the hemorrhagic infarct (133 cm 3 ) and a midline shift of 9 millimeter. After emergent hemicraniectomy, the patient's coma score optimized and the pupils became symmetrical. At 6-and 12-month follow-up a quadrant-anopia was her only residual symptom (mRS 1).
Patient C, a 55-year-old woman, was found unconscious at home. It was estimated that she had been in coma for at least 12 hours. At examination she was comatose (E 1 M 5 V 1 ) and had a fixed and dilated left pupil and bilateral absent corneal reflexes. CT-scan showed a large left temporal hemorrhagic infarct (volume 134 cm 3 ), with uncal herniation and a midline shift of 15 mm. The contrast enhanced CT scan showed a thrombosis of the left transverse and sigmoid sinuses. Despite immediate hemicraniectomy, her clinical condition deteriorated in the following days (E 1 M 2 V 1 ). On day 3, treatment was withdrawn because there was no hope for recovery. She died 5 days later (mRS 6). The diagnosis of CVST was confirmed at autopsy.
Discussion
We present 3 consecutive cases with severe CVST and transtentorial herniation, treated with decompressive hemicraniectomy. This procedure resulted in excellent recovery in 2 patients. Before we changed our policy, similar patients in our center all had a fatal outcome despite maximal conservative treatment and endovascular thrombolysis. 2 The scanty evidence for the efficacy of hemicraniectomy in CVST comes from small case series, [3] [4] [5] [6] [7] summarized in the Table. Including our cases, 11 of 13 patients had a good outcome (mRS Յ3). However, comparability between cases is hampered by a wide variation in preoperative clinical condition (GCS and pupillary reactions) among patients.
There are several reasons why the concept of hemicraniectomy in severe CVST with impending herniation is plausible. First, hemicraniectomy can remove the immediate threat of fatal herniation. Second, decompressive hemicraniectomy has been shown to be effective in young patients with malignant middle cerebral artery infarction and impending herniation. 8 The mechanism causing death is likely to be similar in both diseases. Finally, there is ample evidence that even large venous infarcts in general have a better potential for recovery than arterial infarcts.
To obtain more reliable data, a prospective case registry of hemicraniectomy in CVST will be included in a new, large, international study, the ISCVT-2. 9 Participating centers will report clinical outcome on consecutive patients treated with decompressive hemicraniectomy for CVST. This will minimize selection bias of predominantly successful cases.
In conclusion, our data, supported by earlier case reports and pathophysiological plausibility, suggests that decompressive hemicraniectomy can be life-saving and result in an excellent outcome in the severest cases of CVST. Until more and better data are available, however, the decision to perform hemicraniectomy in CVST remains up to the individual judgment of the treating physician. 
